Entrada Therapeutics, Inc.
← Back to TRDA Overview

Entrada Therapeutics, Inc. (TRDA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.71

Financial Fundamentals

TRDA • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2020-03-31-1.16
2020-06-30-1.16
2020-09-30-17.54
2020-12-31-14.14
2021-03-31-14.63
2021-06-30-12.38
2021-09-30-11.75
2021-12-31-4.82
2022-03-31-3.38
2022-06-30-4.11
2022-09-30-4.91
2022-12-31-4.30
2023-03-31-17.58
2023-06-30-4.84
2023-09-303.71
2023-12-31-13.19
2024-03-314.90
2024-06-302.22
2024-09-30-11.57
2024-12-31156.09
2025-03-31-5.35
2025-06-30-1.61
2025-09-30-1.36
2025-12-31-2.71

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.